Change to Financial Calendar 2023 NeoDynamics will release its Interim Report for January-September 2023 on 28 November 2023.

MFN Publicerad: 27 Nov 2023 19:05

The date for publication of the Interim Report January-September 2023 has been changed from 27 November 2023 to 28 November 2023.

The delay is related to on-going discussions regarding the capitalisation of the company, which are expected to be resolved shortly.

About NeoDynamics
NeoDynamics AB is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound-guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden. NeoNavia is evaluated for breast cancer diagnosis at leading clinics in Europe and launches in USA during 2023. NeoDynamic’s shares are listed on Nasdaq First North Growth Market Stockholm (ticker: NEOD). The company’s Certified Adviser is Redeye AB.

About NeoNavia
NeoNavia is a modern biopsy system with a completely new patented pulse technology intended for ultrasound-guided tissue sampling. Each needle type is driven by the pulse technology providing a more controlled needle insertion and precise placement of the needle in the tumor whilst enabling high-quality tissue samples from both breasts and lymph nodes. The pulse biopsy system NeoNavia is designed to offer clinicians and patients accurate lesion targeting and high tissue yield for correct diagnosis and individualized treatment.

Börskollen

För dig med koll på börsen

Pressmeddelande

Change to Financial Calendar 2023 NeoDynamics will release its Interim Report for January-September 2023 on 28 November 2023.

Bifogade filer

Nyheter om NeoDynamics

Läses av andra just nu

Om aktien NeoDynamics

Senaste nytt